Summary of known phosphorylation sites on Cdc25 family members and the kinases responsible
1. Introduction
Dual specificity phosphatases of the Cdc25 family are critically important regulators of the cell cycle. They activate cyclin-dependent kinases (CDKs) at key cell cycle transitions such as the initiation of DNA synthesis and mitosis. They also represent key points of regulation for pathways monitoring DNA integrity, DNA replication, growth factor signaling and extracellular stress. Since their mis-regulation allows cells to function in a genetically unstable state, it is not surprising that these phosphatases are involved in transformation to a cancerous state. Cdc25 phosphatases are heavily regulated by phosphorylation. Many regulatory phosphorylation sites on Cdc25 influence catalytic activity, substrate specificity, subcellular localization and stability. This chapter summarizes the current literature on the phospho-regulation of these proteins.
2. Yeast genetics and Xenopus oocyte maturation – Setting the stage
The study of cell division in eukaryotes was dramatically changed with the isolation of temperature sensitive “cell division cycle” (
Concurrently, Maturation Promoting Factor (MPF) was discovered through a series of elegant cytoplasmic transfer experiments conducted on frog, starfish and sea urchin oocytes [8-10]. Immature
The cytoplasmic transfer experiments showed that MPF activity correlates with increased protein phosphorylation in donor oocytes [26], targeting a large number of nuclear proteins [27,28]. MPF is a histone H1 kinase, an activity which is still used today to measure CDK function [29]. MPF induces many of the cytological changes associated with mitosis such as nuclear envelope breakdown, chromosome condensation and mitotic spindle formation [30-32]. Mass spectrometry has shown that the single Cdk1 homologue in budding yeast (CDC28) phosphorylates 547 sites on 308 proteins
3. Taxonomic distribution, duplication and divergence of Cdc25 homologues
Cdc25 is present in all eukaryotic cells. The yeasts,
4. Regulation of cell cycle transitions by Cdc25
4.1. The fission yeast G2/M transition – The prototype Cdc25/cyclin-CDK circuit
Regulation of the transition from G2 to mitosis in
4.2. Vertebrate cell cycle
While fission yeast Cdc25 is solely involved in the G2/M transition, Cdc25 orthologues in vertebrates also play a role in G1 and S-phase progression. Vertebrates have several CDK-cyclin complexes which participate in these transitions through positive feedback loops with Cdc25. In addition to associating with cyclin B, Cdk1 associates with cyclin A during late S-phase and G2 [76]. A second CDK, Cdk2, was discovered as a cDNA which could complement the loss of the budding yeast Cdk1 homologue, CDC28 [77]. Cdk2 functions early in the cell cycle and is likewise negatively regulated by phosphorylation of Y15 [78,79]. It forms a complex with Cyclin A and Cyclin E [80,81]. Cdk4 and Cdk6 operate early in G1 in association with D-type cyclins [82]. In many cases a particular cyclin class (ie. A, B, D, E) has multiple members. For the sake of clarity, cyclins will be referred to by their subtype only. Furthermore, only the CDKs and cyclins directly responsible for cell cycle transitions in concert with Cdc25 orthologues will be discussed. For instance, Cdk1/cyclin B is activated by a CDK-Activating Kinase (CAK), a complex of Cdk7 and cyclin H [83], but as CAKs are not activated by Cdc25 they are outside the scope of this review.
4.2.1. Cell cycle re-entry from Go
Most somatic cells spend their time in Go. Cells in Go may commit to entry into the cell cycle when they receive stimuli in the form of growth factors The cells then deactivate the cell cycle repressors which have kept them in Go and transcribe the positive regulators of the next cell cycle transition, G1/S.
In non-dividing cells, the Retinoblastoma protein (Rb) binds to E2F thus preventing transcription of genes required for cell cycle progression including cyclin D, cyclin A and Cdc25A [84-87]. (Figure 1) After exposure to growth factors, cells in Go re-enter the cell cycle through activation of the Ras pathway via the Raf/MAP (Mitogen Activated Protein) kinase pathway [88]. This leads to the degradation of the Cdk4 inhibitors p15INK4B and p16INK4A and the Cdk2 inhibitors p27KIP, p21CIP and induction of cyclin D. Cdk4 and Cdk6 bound to cyclin D inhibit the Rb protein [89] allowing transcription of cyclin E and cyclin A [89,90]. Cdc25A activates Cdk4-cyclin D but not Cdk6-cyclin D
4.2.2. The G1/S transition
Cdc25A is transcribed following relief of Rb-mediated transcriptional repression, reaching its maximal level at the end of G1 and dephosphorylating Y15 on Cdk2 [87,91]. Cdk2 is phosphorylated on Y15 by Wee1 [93]. Dephosphorylation of Cdk2 takes place via both Cdc25A and Cdc25B [94-97]. Cdk2 immunoprecipitated from cell lysates where Cdc25A has been overexpressed has high histone H1 kinase activity and low levels of Y15 phosphorylation [91]. Such overexpression accelerates entry into S-phase through activation of Cdk2-cyclin E [91,98]. DNA-synthesis can be blocked in these cells by injecting them with anti-Cdc25A antibodies [99]. Cdk2-cyclin E and Cdc25A are mutually activated by a positive feedback loop allowing passage of the G1/S boundary [95]. Depletion of Cdk2 or cyclin E prevents phosphorylation of Cdc25A and recombinant Cdc25A can be activated by Cdk2-cyclin E
S-phase initiation requires activation of DNA replication proteins by Cdk2-cyclin A. Injecting G1 cells with anti-cyclin A antibodies stops entry into S-phase [100]. Phosphorylation of the essential DNA replication initiator Cdc6 by Cdk2-cyclin A leads to its nuclear import [101,102]. Cdk2 is recruited to chromatin by the replication initiation factor Cdc45 where it phosphorylates histone H1 and induces chromosome de-condensation [103]. As S-phase progresses high Cdk2-cyclin A activity induces degradation of Cdc6, preventing re-initiation of DNA synthesis at origins which have already fired [102].
Cdc25B has a role late in S-phase as Cdc25B immunoprecipitated from late S-phase HeLa cell extracts is phosphorylated, activated, and able to dephosphorylate Cdk2-cyclin A [97]. The murine homologue of Cdc25B purified from S-phase extracts promotes cyclin A and cyclin E associated histone H1 kinase activity
4.2.3. The G2/M transition
Unlike the simple circuit of Cdc25-Cdc2 activation in fission yeast, the vertebrate G2/M transition involves a series of interconnected loops with positive and negative inputs from a variety of pathways. This led to what could be considered the “traditional model” of G2/M transition in vertebrates with respect to Cdc25 regulation by CDK-cyclin complexes. In reality things may be more complex. Cdc25C is not explicitly required for mitotic entry; siRNA knockdown of Cdc25C does not prevent the G2/M transition [105]. In addition, mouse lines which lack Cdc25B and/or Cdc25C are viable with the only obvious phenotype being a defect in oocyte maturation observed in
4.2.4. Activation of Cdc25B and Cdk1/2-cyclinA
Phosphorylation of human Cdc25B by Cdk1-cyclin A during G2 causes Cdc25B activation but also destabilizes the protein [112,113]. Cdc25B activates Cdk2-cyclinA in a positive feedback loop [114]. Cdk2-cyclin A mediated destabilization of Cdc25B has not been reported, although the Cdk1 and Cdk2 kinase complexes modify Cdc25B to approximately the same degree and have a similar set of substrates [113,115]. However, Cdk2 is the preferred binding partner of cyclin A and is more active than Cdk1-cyclin A during G2 [80,100]. Cdk2 cyclin A has two peaks of activation, one during S-phase and one prior to G2/M. [80,116]. Inhibition of Cdk2-cyclin A delays mitotic entry [109]. Depletion of Cdk1-cyclin A, activation of the CDK inhibitor p21cip, or addition of an inhibitory ATP analogue destabilizes Cdc25B in
Cyclin B accumulates throughout G2 but Cdc25A and Cdc25B are required to induce formation of the Cdk1-cyclin B complex at G2/M [118]. Cdk1-cyclin B interaction occurs earlier in G2 when Cdc25A or Cdc25B are overexpressed. Cdk1 and cyclin B are almost exclusively cytoplasmic during interphase with a small portion of the complex associating with the centrosome at G2/M [119-121]. A population of Cdk2-cyclinA is likewise localized to the centrosomes prior to prophase [116]. In
4.2.5. Everybody into the nucleus
Cyclin B has a cytoplasmic retention sequence which is sufficient to induce cytoplasmic localization of the normally nuclear protein and contains a nuclear export signal (NES) [126]. Nuclear export is blocked by phosphorylation of S126 at the end of prophase [127-129]. Cyclin B is phosphorylated by Cdk1-Cyclin B as starfish oocytes pass the prophase II to metaphase II arrest [130]. Human cyclin B S126 is followed by a proline residue suggesting Cdk1-cyclin B autophosphorylation. Cyclin B is phosphorylated by the
The activated cytoplasmic pool of Cdk1-cyclin B phosphorylates Cdc25B on S160 inducing its nuclear import [135] (All phosphorylated residues on human Cdc25B are numbered according to the sequence of the longest splice variant Cdc25B3). Overexpression of human Cdc25B causes an increase in cells with condensed chromatin, whereas overexpression of Cdc25B-S160G does not induce mitotic entry. S160 phosphorylation does not affect the
Plk1 is involved in human Cdc25B nuclear import following the initial activation of Cdk1-cyclin B. After addition of the Plk1 inhibitor thiophene benzimidazole, nuclear accumulation of GFP-Cdc25B is reduced. Conversely, expression of a constitutively active Plk1 mutant enhances Cdc25 nuclear localization [136]. Co-overexpression of Plk1 and Cdc25B in U2OS osteosarcoma cells induces chromosome condensation to a greater degree compared to cells expressing Plk1 or Cdc25B alone. This is partially dependent on the presence of a functional nuclear localization signal (NLS) in Cdc25B. Plk1 docking to Cdc25B requires prior phosphorylation of S50 by Cdk1/cyclin B [137]. Mass spectrometry identified thirteen phosphorylated Plk1 sites on Cdc25B
4.2.6. Full activation of Cdk1-CyclinB and Cdc25C
Activated Cdk1-cyclin B phosphorylates human Cdc25C on T48, T67, S122, T130, S168 and S214
4.2.7. Mitotic exit
Following chromosome alignment on the metaphase plate a cascade of APC mediated degradation events occurs to reset conditions for the start of the next cell cycle [150]. The APC regulates two important processes required for completion of mitosis. First, it targets Securin, the inhibitory subunit of Separase, which is responsible for Cohesin cleavage and chromosome separation. Second, it targets cyclin A and cyclin B for destruction, inactivating Cdk1. Cyclin B is degraded after the metaphase-anaphase transition while cyclin A is degraded during metaphase. [121]. Cdk1 mediated phosphorylation of Cdc25 paralogues is reversed by Cdc14 family phosphatases. Cdk1-cyclin B phosphorylates human Cdc25A S18, S40, S88, S116, S261 and S283
5. Cdc25 phosphorylation by the DNA damage and replication checkpoint
DNA damage causes activation of checkpoints which delay cell cycle transitions to allow sufficient time for repair. Stalling of replication forks causes a similar cell cycle arrest, with additional need for stabilizing replication forks and/or modulating replication origin firing until the cause of the stalling is eliminated. Checkpoint effector kinases impinge on the central cell cycle machinery by phosphorylating Cdc25. This modification variously inhibits Cdc25 phosphatase activity, induces degradation or creates binding sites for 14-3-3 proteins which modify localization of the protein.
5.1. Fission yeast
Cell cycle arrest following DNA damage requires that Cdc2 is kept in a Y15- phosphorylated, inhibited state [154]. Cdc25 is inhibited through phosphorylation by Chk1 and Cds1 kinases in response to DNA damage and replication fork arrest, respectively [155-157]. Cells over-expressing Cdc25 or expressing a Y15F phospho-mimetic mutation of Cdc2 fail to arrest cell cycle progression after exposure to ionizing radiation [154]. In the absence of Cds1, Chk1 can cause cell cycle arrest following stalling of replication forks by hydroxyurea (HU) exposure. Cells lacking both kinases are unable to arrest [155]. Cds1 also phosphorylates multiple substrates to stabilize stalled replication forks and prevent the occurrence of inappropriate recombination events [158]. Upstream regulation of the DNA damage and replication checkpoint pathway occurs through activation of the ATM (Ataxia-telangiectasia mutated) homologue Rad3 through a well conserved signaling cascade [159].
Phosphorylation of Cdc25 by Chk1 and Cds1 creates binding sites for the 14-3-3 homologues Rad24 and Rad25 [160,161]. Phosphorylation and 14-3-3 binding stabilizes Cdc25, a phenomena referred to as “stockpiling”, thought to allow the cell to rapidly re-enter the cell cycle once replication or DNA damage arrest has been lifted [70]. The first Chk1/Cds1 phosphorylated Cdc25 residue identified, S99, partially impairs the replication and DNA damage checkpoint when mutated to alanine [157]. S99 modified Cdc25 is also phosphorylated on S192 and S359 by Cds1 and Chk1
5.2. Vertebrate Cdc25 regulation by DNA damage and replication checkpoints
In vertebrate cells detection of DNA damage is relayed through ATM and ATR (ATM-Related) to two checkpoint effectors, Chk1 and Chk2. While the
5.2.1. G1/S and Intra-S checkpoints
The G1/S checkpoint prevents the start of DNA synthesis in the presence of DNA damage while the Intra-S checkpoint protects replication forks, prevents activation of late replication origins, and keeps the cell from entering mitosis until S-phase is completed. G1-S checkpoint arrest is manifested through inhibition of Cdc25A, thus preventing activation of Cdk4-cyclin D and Cdk2-cyclin E. The checkpoint also activates p53 resulting in the induction of the Cdk2 inhibitor p21CIP and the targeting of Cyclin E to the SCF complex to reinforce Cdk2 inhibition [165]. In rat fibroblasts UV induced DNA damage during G1 results in cell cycle arrest at the G1/S transition requiring inhibition of Cdc25A and phosphorylation of Cdk4-Y14 [166]. In U2OS osteosarcoma cells Cdk2-cyclin E kinase activity decreases and Y15 phosphorylation increases coincident with Cdc25A degradation following UV exposure [167]. Conversely, Cdc25A overexpression in UV exposed U2OS osteosarcoma cells results in bypass of the checkpoint and dephosphorylation of Cdk2-cyclin E. Cdc25A inhibition involves a combination of destabilization and inhibition of phosphatase activity by Chk1 [167]. Treatment with caffeine (an ATM/ATR inhibitor) or the Chk1 inhibitor UNC-01, or depletion of Chk1, stabilizes the phosphatase [167,168]. In humans, Chk1 phosphorylates Cdc25A S76, S124, S178, and T507 [168-170]. Cdc25A catalytic activity is reduced three-fold when it is phosphorylated by hChk1
Human Cdc25A S76, S124 and/or S178 are identified in several publications as “S75, S123 and S177,” respectively [168,169,174-176]. In the original cloning of human Cdc25A [37], there are several substitutions in the N-terminus (Accession: AAA58415.1) and a one residue gap corresponding to residue R12 in all other full length human Cdc25A sequences in the NCBI database (Accession: P30304). Residues have been re-numbered as per “P30304” for the sake of consistency.
Cdc25A S76, S124, S178 and T507 match the consensus site for 14-3-3 binding, RXXpS/T [177]. However, only the Chk1 dependent phosphorylation of S178 and T507 results in association with 14-3-3 [170]. Substitution of these residues to alanine results in a complete loss of 14-3-3 interaction
Defects in the Intra-S checkpoint allow replication of damaged DNA [173,176,181]. In mammalian cells, DNA damage results in destabilization of Cdc25A and inhibition of Cdk2 [173]. Cdk2 is involved in loading the Cdc45 origin binding factor. Inhibition of Cdc25A stops further origin firing once DNA damage is detected [182]. Cdc25A is also unstable after HU induced replication fork stalling, which unlike in fission yeast, is controlled by activation of Chk1 in mammalian cells [183].
The mechanism by which Cdc25A is destabilized following DNA structure checkpoint activation is well understood (Figure 3). Human Cdc25A phosphorylation by Chk1 following S-phase DNA damage causes degradation by F-box protein β-TrCP associated with the Skp1-cullin-Fbox (SCF) complex [171,184]. Mutating the destruction box or KEN box (APC interaction motifs) of Cdc25A does not stabilize the protein following exposure to ionizing radiation [152]. This indicates that SCF-mediated degradation of Cdc25A after DNA damage is independent of the cell cycle regulated APC-mediated degradation which occurs at mitotic exit. β-TrCP recognizes a degron motif of DSG(X)4S where both serine residues are phosphorylated [185]. siRNA knockdown of β-TrCP causes stabilization of Cdc25A, and radiation-resistant DNA synthesis in cells exposed to ionizing radiation [171,184]. Human Cdc25A contains such a motif: DS82GFCLDS88. The S88A substitution does not stabilize the phosphatase, suggesting that S88 phosphorylation is not explicitly required for β-TrCP binding to Cdc25A [171]. Following ionizing radiation, Chk1 primes Cdc25A for destruction through phosphorylation of S76 [171,186]. The NimA-related NEK11 kinase targets Cdc25A S82 and S88, within the DSG degron sequence [187]. Depletion of NEK11 causes a marked decrease in S82 and S88 phosphorylation
Following ATM activation, Chk2 phosphorylates and activates the oncogene p53, and inhibits its negative regulator MDM2 after ionizing radiation [188-191]. p53 then induces the Cdk2-cyclin E inhibitor p21WAF [192]. p53 also activates Glycogen Synthase Kinase (GSK-3β), which phosphorylates human Cdc25A S76 following a priming phosphorylation of S80 which can be targeted
Cdc25A S76, S124, S178 and T507 match the consensus site for 14-3-3 binding RXXpS/T [177]. However, only the Chk1 dependent phosphorylation of S178 and T507 results in association with 14-3-3 [170]. Substitution of these residues to alanine results in a complete loss of 14-3-3 interaction
Following exposure to ionizing radiation during G1 phosphorylation of Cdc25A on S124 by Chk2 prevents entry to S-phase [173]. Chk2 cannot efficiently phosphorylate Cdc25A on S76 and so cannot induce Cdc25A degradation by the β-TrCP route [206]. The mechanism by which S124 phosphorylation induces Cdc25A degradation is not clear because it is not required for degradation via β-TrCP [173]. S124 conforms to a 14-3-3 phospho-serine binding site, but doesn’t bind 14-3-3 [170]. In contrast to the effects of Cdc25A phosphorylation sites discussed thus far, modification of
5.2.2. G2/M DNA damage checkpoint
The response to damage in G2 is dependent on the nature of the damage signal. Exposure to UV activates p38 MAP kinase and checkpoint arrest is independent of ATM and ATR since the arrest is not caffeine sensitive [208]. The primary target following UV irradiation is Cdc25B and although p38 can phosphorylate Cdc25C
A number of conflicting reports have appeared relating to Cdc25B regulation following UV exposure. Some groups have reported that UV has no effect on Cdc25B protein levels [208,210], but others have shown that UV causes either MAP kinase mediated Cdc25B degradation or Cdc25B accumulation [205,208,211]. Cell line specific effects have no doubt contributed to these inconsistencies as human molecular biology relies heavily on transformed cell lines and mis-regulation of Cdc25B is a common phenomenon in tumors [212]. Cdc25B isolated from UV irradiated A2058 melanoma cells still retains a substantial portion of its Y15 phosphatase activity and is localized to the nucleus [213]. In HeLa cells Cdc25B is localized almost exclusively to the cytoplasm as detected by cell fractionation and immunofluorescence [120]. Variation in the apparatus used for UV irradiation could also have contributed to contradictory accounts of Cdc25B regulation. A recent re-examination of the effect of UV on Cdc25B showed that after 10 J/m2 exposure, Cdc25B levels did not decrease, although following 60 J/m2 Cdc25B was clearly downregulated [214]. Exposure of U2OS osteosarcoma cells to 10 J/m2 UV leads to Cdc25B nuclear export. Based on chemical inhibitor experiments Cdc25B downregulation is not mediated by ATM/ATR, p38 MAPK or JNK, but rather following 60 J/m2, by inhibiting Cdc25 translation. The eukaryotic initiation factor regulating Cdc25B expression, eIF2α, is phosphorylated and inhibited following UV exposure [215]. UV mediated DNA damage during G2 involves human Cdc25B S323 phosphorylation through the p38 kinase during interphase [208]. ATM/ATR inhibitor caffeine and the Chk1 inhibitor UNC-01 have no effect on UV mediated checkpoint arrest. Isoforms 14-3-3β and 14-3-3ε bind preferentially to Cdc25B phosphorylated S323, allowing its nuclear export [216]. Nuclear export of Cdc25B is abolished in cells expressing the Cdc25B S323A substitution, regardless of which 14-3-3 isoform is co-expressed [216]. Two amino-truncated Cdc25B isoforms localize to the nucleus
Cdk1 activation is prevented by UV induced checkpoint activity coincident with the appearance of a phosphorylated form of Cdc25C [213]. In contrast with fission yeast Cdc25, which gradually accumulates in the nucleus during G2, human Cdc25C is primarily localized to the cytoplasm during interphase and only enters the nucleus at mitotic entry [217]. Thus, nuclear export of Cdc25C is not a requirement for G2 DNA damage response, since the phosphatase is already cytoplasmic at this time. However, exposure to ionizing radiation decreases the enzymatic activity of human Cdc25C [218]. Several research groups showed relatively early in the Cdc25 phosphorylation story that residue S216 is phosphorylated by Chk1 [219-221] and Chk2
Although Cdc25C S216A is a relatively poor substrate for Chk1 compared to the wildtype protein, Chk1 can still execute some degree of phosphorylation on the mutant phosphatase [220]. This observation suggests the possibility that additional Cdc25C phosphorylation negatively regulates its enzymatic activity. Recent bioinformatics approaches to generate profiles from peptide binding arrays based on three diverse 14-3-3 binding sites have generated an improved 14-3-3 binding motif consensus [225]. This helped to identify two additional phosphorylated Cdc25C residues, Ser247 and Ser263, which interact with 14-3-3. Mutation of either residue to alanine reduces 14-3-3 binding, but neither of these mutant peptides was affected by Cdc25 S216 phosphorylation when expressed in cells. S263 was previously identified in an isolated report which showed phosphorylation of this residue induces Cdc25B nuclear export [226]. Cdc25C purified from cells treated with the topoisomerase II inhibitor etoposide is phosphorylated on S263, but S263A substitution results in enhanced nuclear localization. The kinase targeting this residue has yet to be determined experimentally. However, the residues surrounding S263 (KKTVpSLCD) conform to a Chk1 consensus site as Chk1 can tolerate a lysine (K) at the -3 position relative to the phosphorylated serine or threonine
Regulation of
Cdc25A is considered to regulate the G1/S transition in the “Traditional Model” of the human cell cycle but it also has a significant role in mitotic entry. As such, Cdc25A is an important target of the DNA damage checkpoint. In fact, mice lacking Cdc25B and Cdc25C do not have a G2/M checkpoint defect [106,107]. Phosphorylation by Chk1 causes degradation of Cdc25A following DNA damage during G2 ionizing radiation and exposure to the DNA intercalating agent adriamycin [172,181].
5.3. Chk1 regulation of Cdc25 orthologues in unperturbed cell cycles
Cdc25A, B and C are all phosphorylated by Chk1 in the absence of externally induced DNA damage. As Cdc25 phosphatases are such potent positive regulators of cell cycle transitions it is perhaps not surprising that the cell maintains their activity at a low level until their precise point of activation. Chk1 regulates human Cdc25A stability during unperturbed cell cycles. Phosphorylation of S82 and S88 can be detected using phospho-specific antibodies in unperturbed cells [184]. Depletion of the S82/S88 kinase NEK1 and S76 kinase CK1ε by siRNA, results in Cdc25A stabilization in the absence of DNA damage [187,199]. Cdc25A S124 phosphorylation by Chk1 also occurs in the absence of damage and destabilizes the phosphatase [168,169,200]. Inhibiting ATM/ATR, or a variety of upstream checkpoint components, also stabilizes in the absence of externally induced DNA damage which may indicate there is some basal level of spontaneous damage checkpoint signaling [232]. Cdc25A is also phosphorylated by Casein kinase 2β (CK2β) in a damage independent manner [233]. CK2 phosphorylates human Cdc25C T236 adjacent to the NLS
Human Cdc25B is phosphorylated
Chk1 phosphorylation of human Cdc25C and nuclear export by 14-3-3 binding keeps the phosphatase cytoplasmic during unperturbed cell cycles [217]. Nuclear localization of Cdc25C(S216A) is enhanced, suggesting that part of the function of 14-3-3 binding is to obscure the NLS located adjacent to this residue [224]. Overexpression of Cdc25C(S216A) induces a higher degree of premature mitotic entry [217].
Although Cdc25A and Cdc25B are dispensable for embryonic development, Chk1 and ATR kinases are essential [242,243]. The Cdc25B/14-3-3 interaction is important for maintaining G2 arrest, and inhibiting germinal vesicle breakdown in
In
5.4. Cdk1 phosphorylation of Cdc25 precludes checkpoint mediated inhibition during mitosis
If Cdc25C is phosphorylated and inactivated during interphase via 14-3-3 binding, how is it then activated at mitotic entry? Cdk1-cyclin B phosphorylation of Cdc25C causes 14-3-3 dissociation and allows removal of interphase phosphorylations. Re-phosphorylation of these residues is simultaneously blocked. Cdk1-cyclin B thus potentiates Cdc25C for its pro-mitotic function and ensures that it remains active. The region surrounding S216 in human Cdc25C and S287 in
PP1 phosphatase removes S287 phosphorylation once 14-3-3 has dissociated [251]. Binding of PP1 to
There are no Cdc2 phosphorylation motifs (S/TP) directly upstream of any of the twelve Cds1
6. Cdc25 phosphorylation by MAP kinase cascades
In addition to regulation by DNA damage and DNA replication checkpoints, Cdc25 is the target of several MAPK cascades responding to stress and mitogenic signals. A detailed description of the variety of MAPK pathways is outside of the scope of this manuscript, but excellent reviews are available [265]. In general, MAP kinase cascades involve the sequential activation of three kinases; a MAP kinase kinase kinase (MAPKKK) phosphorylates a MAP kinase kinase (MAPKK), which phosphorylates a MAP kinase (MAPK). There are three such cascades which are salient to our discussion of Cdc25 regulation.
6.1. Raf/MEK/ERK
The ERK1/ERK2 MAPKs are activated by Raf MAPKKKs working on MEK1/MEK2 MAPKKs. This cascade is primarily activated by extracellular signaling through receptor tyrosine kinases in response to mitogenic signals [266]. During Cyto-Static Factor arrest in mature
6.2. p38 and JNK MAPKs
The p38 and JNK kinases activate in response to extracellular stimuli such as heatshock, oxidative stress, ionizing radiation, UV and growth factor deprivation. Both are activated by MAPKKs of the MKK family which are themselves activated by a large variety of MAPKKKs. We have already discussed the function of p38 in response to UV irradiation. p38 also phosphorylates human Cdc25A on S124 and S76 in response to osmotic stress, destabilizing the protein [168] and a 42 C heatshock causes p38 and Chk2 to phosphorylate S76 and S178 of human Cdc25A, respectively [175]. MAPKAP kinase 2 (MK2) functions downstream of p38 and regulates G1 and S-phase cell cycle progression in response to UV [210]. Downstream of p38, it phosphorylates RxxS/T motifs and activation of MK2 correlates with increased binding of 14-3-3 to Cdc25B. p38 and MK2 kinase form a tight complex and are imported into the nucleus together, so previous work showing that p38 directly phosphorylates S216 on Cdc25C and S323 on Cdc25B may in fact have been inadvertently monitoring MK2 activity [279]. Cdc25A may also be an MK2 substrate as MK2 knockdowns ablate the G1 and S-phase checkpoints. JNK activity targets two serines within the region DAGLCMDS101PS103P of the DSG degron on human Cdc25B [280]. Simultaneous S101A and S103A substitution prevents β-TrCP binding and Cdc25B ubiquitination. JNK also phosphorylates Cdc25C on S168 inhibiting its phosphatase activity [281,282]. This residue is transiently phosphorylated
6.3. The S. pombe stress activated MAP kinase pathway
In fission yeast, Cdc25 is phosphorylated by the CamKII homologue Srk1 in response to extracellular stress [283]. Srk1 is activated downstream of the Spc1 MAPK, Wis1 MAPKK, and Win1 or Wak1MAPKKKs [284]. This phosphorylation occurs on residues also targeted by Cds1 as Cdc25(9A) is not sensitive to Srk1 mediated inhibition [283]. Srk1 phosphorylation of Cdc25 results in its nuclear export, similar to the response to DNA damage and replication arrest.
7. Other kinases which phosphorylate Cdc25s
PKA prevents oocyte maturation by inhibition of Polo kinase mediated Cdc25 activation, and deactivating the Mos/MEK/ERK MAP kinase cascade which inhibits Myt1 [285]. Progesterone exposure in
Pim1 is a serine/threonine kinase induced by the SAT3 and SAT5 transcription factors following cytokine exposure thus linking pro-proliferative signals to the cell cycle control machinery [288]. Pim1 phosphorylates and activates Cdc25A and represses the Cdk4/6 inhibitor p21CIP to encourage the G1/S transition [289,290]. Pim1 is also able to phosphorylate and inhibit the CamKII homologue c-TAK and accelerate Cdc25C mediated mitotic entry [291] PAR-1/MARK (partitioning-defective 1/Microtubule affinity-Regulating Kinase) protein homologue pEG3 phosphorylates human Cdc25A S263, Cdc25B S169 and Cdc25C S216 [292,293]. Overexpressing pEg3 results in G2 arrest which can be reversed by co-expressing Cdc25B [292]. Anti-phospho PAR1 S169 antibodies stain spindle pole and centrosome in immunofluorescence experiments [293]. In
8. Cdc25 and disease
Cdc25 orthologues are the subject of much attention as they are commonly upregulated in human tumors [296]. This is perhaps not surprising considering the role of Cdc25 inhibition in maintaining genomic stability and the regulation of these phosphatases by Rb, p53 and a number of other oncogenes. Cdc25A and Cdc25B themselves are oncogenes in humans [212]. Cdc25B is overexpressed in 32% of breast cancer tissue samples, and high Cdc25B levels correlate with high incidences of recurrence and decreased 10 year survival [212]. Overexpression of Cdc25A is similarly linked to poor clinical outcome [296,297]. Cells bearing oncogenic mutations of myc have elevated Cdc25A and Cdc25B levels [298]. Anti-Cdc25B autoantibody has been shown to be a predictor of poor prognosis in esophageal cancer patients [299]. Overexpression of Cdc25B has recently been shown to cause a variety of S-phase effects including increased Cdc45 recruitment to chromatin, impairment of replication fork progression DNA damage and chromosome instability [300].
An interesting link between Cdc25 and disease comes from the finding that the HIV-1 protein vpr causes G2/M arrest [301]. When expressed in
9. Conclusion
It has been more than thirty five years since Cdc25 was first isolated as an elongated temperature-sensitive fission yeast mutant and twenty one years since its biochemical function was determined. The field of cell cycle research and the study of Cdc25 in particular are extremely active with numerous new manuscripts appearing each year. This research has revealed that Cdc25 is one of the most intricately regulated proteins in the cell. Cdc25 accepts input from numerous pathways and checkpoints monitoring whether conditions inside and outside the cell are permissive for cell cycle progression. When conditions warrant caution, Cdc25 is inhibited by phosphorylation leading to alterations in its catalytic activity, cellular localization, substrate recognition and stability. When the green light is given Cdc25 participates in an intricate series of interconnected positive feedback loops with the beating heart of cell cycle regulation, the Cyclin-CDK complex. When the cell loses control of Cdc25 regulation, the results are deadly.
Acknowledgement
Thank you to Silja Freitag for her critical reading of this manuscript. This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada to PGY.
References
- 1.
Hartwell L. H. Culotti J. Reid B. 1970 Genetic control of the cell-division cycle in yeast. I. Detection of mutants. Proc Natl Acad Sci U S A66 2 352 359 - 2.
Hartwell L. H. Mortimer R. K. Culotti J. Culotti M. 1973 Genetic control of the cell division cycle in yeast: V. Genetic analysis of cdc mutants. Genetics74 2 267 286 - 3.
Nurse P. Thuriaux P. Nasmyth K. 1976 Genetic control of the cell division cycle in the fission yeast Schizosaccharomyces pombe. Mol Gen Genet146 2 167 178 - 4.
Nurse P. 1975 Genetic control of cell size at cell division in yeast. Nature256 5518 547 551 - 5.
Fantes P. 1979 Epistatic gene interactions in the control of division in fission yeast. Nature279 5712 428 430 - 6.
Fantes PA. 1981 Isolation of cell size mutants of a fission yeast by a new selective method: characterization of mutants and implications for division control mechanisms. J Bacteriol146 2 746 754 - 7.
Thuriaux P. Nurse P. Carter B. 1978 Mutants altered in the control co-ordinating cell division with cell growth in the fission yeast Schizosaccharomyces pombe. Mol Gen Genet161 2 215 220 - 8.
Kishimoto T. Kanatani H. 1976 Cytoplasmic factor responsible for germinal vesicle breakdown and meiotic maturation in starfish oocyte. Nature260 5549 321 322 - 9.
Masui Y. Markert C. L. 1971 Cytoplasmic control of nuclear behavior during meiotic maturation of frog oocytes. J Exp Zool177 2 129 145 - 10.
Maller JL. 1990 Xenopus oocytes and the biochemistry of cell division. Biochemistry29 13 3157 3166 - 11.
Smith LD, Ecker RE. 1971 The interaction of steroids with Rana pipiens Oocytes in the induction of maturation. Dev Biol25 2 232 247 - 12.
Murray AW, Solomon MJ, Kirschner MW. 1989 The role of cyclin synthesis and degradation in the control of maturation promoting factor activity. Nature339 6222 280 286 - 13.
Newport J. Kirschner M. 1982 A major developmental transition in early Xenopus embryos: II. Control of the onset of transcription. Cell30 3 687 696 - 14.
Newport J. Kirschner M. 1982 A major developmental transition in early Xenopus embryos: I. characterization and timing of cellular changes at the midblastula stage. Cell30 3 675 686 - 15.
Dunphy W. G. Brizuela L. Beach D. Newport J. 1988 The Xenopus cdc2 protein is a component of MPF, a cytoplasmic regulator of mitosis. Cell54 3 423 431 - 16.
Evans T. Rosenthal E. T. Youngblom J. Distel D. Hunt T. 1983 Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division. Cell33 2 389 396 - 17.
Gautier J. Minshull J. Lohka M. Glotzer M. Hunt T. Maller J. L. 1990 Cyclin is a component of maturation-promoting factor from Xenopus. Cell60 3 487 494 - 18.
Patra D. Dunphy W. G. 1996 Xe-9 a Xenopus Suc1/Cks homolog, has multiple essential roles in cell cycle control. Genes Dev 10(12):1503-1515. - 19.
Gautier J. Norbury C. Lohka M. Nurse P. Maller J. 1988 Purified maturation-promoting factor contains the product of a Xenopus homolog of the fission yeast cell cycle control gene cdc2+. Cell54 3 433 439 - 20.
Nurse P. Bissett Y. 1981 Gene required in G1 for commitment to cell cycle and in G2 for control of mitosis in fission yeast. Nature292 5823 558 560 - 21.
Beach D. Durkacz B. Nurse P. 1982 Functionally homologous cell cycle control genes in budding and fission yeast. Nature300 5894 706 709 - 22.
Hagan I. Hayles J. Nurse P. 1988 Cloning and sequencing of the cyclin-related cdc13+ gene and a cytological study of its role in fission yeast mitosis. J Cell Sci 91 ( Pt 4)(Pt 4):587-595. - 23.
Booher R. Beach D. 1988 Involvement of cdc13+ in mitotic control in Schizosaccharomyces pombe: possible interaction of the gene product with microtubules. EMBO J7 8 2321 2327 - 24.
Gautier J. MJ Solomon Booher. RN Bazan J. F. Kirschner M. W. 1991 Cdc25 is a Specific Tyrosine Phosphatase that Directly Activates34cdc2 Cell 67(1):197-211. - 25.
Millar J. B. Mc Gowan C. H. Lenaers G. Jones R. Russell P. 1991 80cdc25 mitotic inducer is the tyrosine phosphatase that activates p34cdc2 kinase in fission yeast. EMBO J 10(13):4301-4309. - 26.
Doree M. Peaucellier G. Picard A. 1983 Activity of the maturation-promoting factor and the extent of protein phosphorylation oscillate simultaneously during meiotic maturation of starfish oocytes. Dev Biol99 2 489 501 - 27.
Maller J. Wu M. Gerhart J. C. 1977 Changes in protein phosphorylation accompanying maturation of Xenopus laevis oocytes. Dev Biol58 2 295 312 - 28.
Mazzei G. Guerrier P. 1982 Changes in the pattern of protein phosphorylation during meiosis reinitiation in starfish oocytes. Dev Biol91 2 246 256 - 29.
Wiblet M. 1974 Protein kinase activities during maturation in Xenopus laevis oocytes. Biochem Biophys Res Commun60 3 991 998 - 30.
Margalit A. Vlcek S. Gruenbaum Y. Foisner R. 2005 Breaking and making of the nuclear envelope. J Cell Biochem95 3 454 465 - 31.
Abe S. Nagasaka K. Hirayama Y. Kozuka-Hata H. Oyama M. Aoyagi Y. et al. 2011 The initial phase of chromosome condensation requires Cdk1-mediated phosphorylation of the CAP-D3 subunit of condensin II. Genes Dev25 8 863 874 - 32.
Glotzer M. 2009 The 3Ms of central spindle assembly: microtubules, motors and MAPs. Nat Rev Mol Cell Biol10 1 9 20 - 33.
Holt L. J. Tuch B. B. Villen J. Johnson A. D. Gygi S. P. DO Morgan 2009 Global analysis of Cdk1 substrate phosphorylation sites provides insights into evolution. Science325 5948 1682 1686 - 34.
Enserink JM, Kolodner RD. 2010 An overview of Cdk1 controlled targets and processes. Cell Div 5:11. - 35.
Russell P. Moreno S. Reed S. I. 1989 Conservation of mitotic controls in fission and budding yeasts. Cell57 2 295 303 - 36.
Nagata A. Igarashi M. Jinno S. Suto K. Okayama H. 1991 An additional homolog of the fission yeast cdc25+ gene occurs in humans and is highly expressed in some cancer cells. New Biol3 10 959 968 - 37.
Galaktionov K. Beach D. 1991 Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: evidence for multiple roles of mitotic cyclins. Cell67 6 1181 1194 - 38.
Sadhu K. Reed S. I. Richardson H. Russell P. 1990 Human homolog of fission yeast cdc25 mitotic inducer is predominantly expressed in G2. Proc Natl Acad Sci U S A87 13 5139 5143 - 39.
Wickramasinghe D. Becker S. Ernst M. K. Resnick J. L. Centanni J. M. Tessarollo L. et al. 1995 Two CDC25 homologues are differentially expressed during mouse development. Development121 7 2047 2056 - 40.
Okazaki K. Hayashida K. Iwashita J. Harano M. Furuno N. Sagata N. 1996 Isolation of a cDNA encoding the X enopus homologue of mammalian Cdc25A that can induce meiotic maturation of oocytes. Gene 178(1-2):111-114. - 41.
Forrest AR, McCormack AK, DeSouza CP, Sinnamon JM, Tonks ID, Hayward NK, et al. 1999 Multiple splicing variants of cdc25B regulate G2/M progression. Biochem Biophys Res Commun260 2 510 515 - 42.
Bonnet J. Mayonove P. Morris M. C. 2008 Differential phosphorylation of Cdc25C phosphatase in mitosis. Biochem Biophys Res Commun370 3 483 488 - 43.
Wegener S. Hampe W. Herrmann D. Schaller H. C. 2000 Alternative splicing in the regulatory region of the human phosphatases CDC25A and CDC25C. Eur J Cell Biol79 11 810 815 - 44.
Jullien D. Bugler B. Dozier C. Cazales M. Ducommun B. 2011 Identification of N-terminally truncated stable nuclear isoforms of CDC25B that are specifically involved in G2/M checkpoint recovery. Cancer Res71 5 1968 1977 - 45.
Kumagai A. Dunphy W. G. 1992 Regulation of the cdc25 protein during the cell cycle in Xenopus extracts. Cell70 139 151 - 46.
Rime H. Huchon D. De Smedt V. Thibier C. Galaktionov K. Jessus C. et al. 1994 Microinjection of Cdc25 protein phosphatase into Xenopus prophase oocyte activates MPF and arrests meiosis at metaphase I. Biol Cell82 1 11 22 - 47.
Ashcroft N. R. ME Kosinski Wickramasinghe. D. Donovan P. J. Golden A. 1998 The four cdc25 genes from the nematode Caenorhabditis elegans. Gene 214(1-2):59-66. - 48.
Alphey L. Jimenez J. White-Cooper H. Dawson I. Nurse P. Glover D. M. 1992 twine, a cdc25 homolog that functions in the male and female germline of Drosophila. Cell69 6 977 988 - 49.
Edgar BA, O’Farrell PH. 1989 Genetic control of cell division patterns in the Drosophila embryo. Cell57 1 177 187 - 50.
Kumagai A. Dunphy W. G. 1991 The cdc25 protein controls tyrosine dephosphorylation of the cdc2 protein in a cell-free system. Cell64 5 903 914 - 51.
Khadaroo B. Robbens S. Ferraz C. Derelle E. Eychenie S. Cooke R. et al. 2004 The first green lineage cdc25 dual-specificity phosphatase. Cell Cycle3 4 513 518 - 52.
Landrieu I. da Costa. M. De Veylder L. Dewitte F. Vandepoele K. Hassan S. et al. 2004 A small CDC25 dual-specificity tyrosine-phosphatase isoform in Arabidopsis thaliana. Proc Natl Acad Sci U S A101 36 13380 13385 - 53.
Sorrell D. A. Chrimes D. Dickinson J. R. Rogers H. J. Francis D. 2005 The Arabidopsis CDC25 induces a short cell length when overexpressed in fission yeast: evidence for cell cycle function. New Phytol165 2 425 428 - 54.
Booher RN, Alfa CE, Hyams JS, Beach DH. 1989 The fission yeast cdc2/cdc13/suc1 protein kinase: regulation of catalytic activity and nuclear localization. Cell58 3 485 497 - 55.
Booher R. Beach D. 1987 Interaction between cdc13+ and cdc2+ in the control of mitosis in fission yeast; dissociation of the G1 and G2 roles of the cdc2+ protein kinase. EMBO J6 11 3441 3447 - 56.
Martin-Castellanos C. MA Blanco de Prada. J. M. Moreno S. 2000 The puc1 cyclin regulates the G1 phase of the fission yeast cell cycle in response to cell size. Mol Biol Cell11 2 543 554 - 57.
Durkacz B. Carr A. Nurse P. 1986 Transcription of the cdc2 cell cycle control gene of the fission yeast Schizosaccharomyces pombe. EMBO J5 2 369 373 - 58.
Creanor J. Mitchison J. M. 1996 The kinetics of the B cyclin56cdc13 and the phosphatase p80cdc25 during the cell cycle of the fission yeast Schizosaccharomyces pombe. J Cell Sci 109 ( Pt 6)(Pt 6):1647-1653. - 59.
Ducommun B. Draetta G. Young P. Beach D. 1990 Fission yeast cdc25 is a cell-cycle regulated protein. Biochem Biophys Res Commun167 1 301 309 - 60.
Frazer C. Young P. G. 2011 Redundant mechanisms prevent mitotic entry following replication arrest in the absence of Cdc25 hyper-phosphorylation in fission yeast. PLoS One 6(6):e21348. - 61.
Den Haese. G. J. Walworth N. Carr A. M. Gould K. L. 1995 The Wee1 protein kinase regulates T14 phosphorylation of fission yeast Cdc2. Mol Biol Cell6 4 371 385 - 62.
Gould K. L. Nurse P. 1989 Tyrosine phosphorylation of the fission yeast cdc2+ protein kinase regulates entry into mitosis. Nature342 6245 39 45 - 63.
Lundgren K. Walworth N. Booher R. Dembski M. Kirschner M. Beach D. 1991 Mik1 and Wee1 Cooperate in the Inhibitory Tyrosine Phosphorylation of Cdc2. Cell64 6 1111 1122 - 64.
MS Lee Enoch. T. Piwnica-Worms H. 1994 Mik1+ Encodes a Tyrosine Kinase that Phosphorylates34cdc2 on Tyrosine 15. J Biol Chem 269(48):30530-30537. - 65.
Russell P. Nurse P. 1987 Negative regulation of mitosis by wee1+, a gene encoding a protein kinase homolog. Cell49 4 559 567 - 66.
Parker L. L. Atherton-Fessler S. Piwnica-Worms H. 1992 107wee1 is a Dual-Specificity Kinase that Phosphorylates P34cdc2 on Tyrosine 15. Proc Natl Acad Sci U S A 89(7):2917-2921. - 67.
Featherstone C. Russell P. 1991 Fission yeast107wee1 mitotic inhibitor is a tyrosine/serine kinase. Nature 349:808-811. - 68.
Chua G. Lingner C. Frazer C. Young P. G. 2002 The sal3(+) gene encodes an importin-beta implicated in the nuclear import of Cdc25 in Schizosaccharomyces pombe. Genetics162 2 689 703 - 69.
Rupes I. BA Webb Mak. A. Young P. G. 2001 G2/M arrest caused by actin disruption is a manifestation of the cell size checkpoint in fission yeast. Mol Biol Cell12 12 3892 3903 - 70.
Kovelman R. Russell P. 1996 Stockpiling of Cdc25 during a DNA replication checkpoint arrest in Schizosaccharomyces pombe. Mol Cell Biol16 1 86 93 - 71.
Moreno S. Nurse P. 1990 Substrates for34cdc2 in vivo veritas? Cell 61(4):549-551. - 72.
Shenoy S. Choi J. K. Bagrodia S. Copeland T. D. Maller J. L. Shalloway D. 1989 Purified maturation promoting factor phosphorylates60c at the sites phosphorylated during fibroblast mitosis. Cell 57(5):763-774. - 73.
Wolfe BA, Gould KL. 2004 Fission yeast Clp1p phosphatase affects G2/M transition and mitotic exit through Cdc25p inactivation. EMBO J23 4 919 929 - 74.
Mulvihill D. P. Petersen J. Ohkura H. Glover D. M. Hagan I. M. 1999 Plo1 kinase recruitment to the spindle pole body and its role in cell division in Schizosaccharomyces pombe. Mol Biol Cell10 8 2771 2785 - 75.
Charles J. F. Jaspersen S. L. Tinker-Kulberg R. L. Hwang L. Szidon A. DO Morgan 1998 The Polo-related kinase Cdc5 activates and is destroyed by the mitotic cyclin destruction machinery in S. cerevisiae. Curr Biol8 9 497 507 - 76.
Katsuno Y. Suzuki A. Sugimura K. Okumura K. Zineldeen D. H. Shimada M. et al. 2009 Cyclin A-Cdk1 regulates the origin firing program in mammalian cells. Proc Natl Acad Sci U S A106 9 3184 3189 - 77.
Elledge SJ, Spottswood MR. 1991 A new human34 protein kinase, CDK2, identified by complementation of a cdc28 mutation in Saccharomyces cerevisiae, is a homolog of Xenopus Eg1. EMBO J 10(9):2653-2659. - 78.
Gu Y. Rosenblatt J. DO Morgan 1992 Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J11 11 3995 4005 - 79.
Elledge S. J. Richman R. Hall F. L. Williams R. T. Lodgson N. Harper J. W. 1992 CDK2 encodes a 33-kDa cyclin A-associated protein kinase and is expressed before CDC2 in the cell cycle. Proc Natl Acad Sci U S A89 7 2907 2911 - 80.
Rosenblatt J. Gu Y. DO Morgan 1992 Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A. Proc Natl Acad Sci U S A89 7 2824 2828 - 81.
Guadagno TM, Newport JW. 1996 Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity. Cell84 1 73 82 - 82.
Bates S. Bonetta L. Mac Allan. D. Parry D. Holder A. Dickson C. et al. 1994 CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1. Oncogene9 1 71 79 - 83.
Fisher RP, Morgan DO. 1994 A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell78 4 713 724 - 84.
Weinberg RA. 1995 The retinoblastoma protein and cell cycle control. Cell81 3 323 330 - 85.
Dyson N. 1998 The regulation of E2F by pRB-family proteins. Genes Dev12 15 2245 2262 - 86.
Vidal A. Koff A. 2000 Cell-cycle inhibitors: three families united by a common cause. Gene 247(1-2):1-15. - 87.
Chen X. Prywes R. 1999 Serum-induced expression of the cdc25A gene by relief of E2F-mediated repression. Mol Cell Biol19 7 4695 4702 - 88.
Malumbres M. Pellicer A. 1998 RAS pathways to cell cycle control and cell transformation. Front Biosci 3:d887 912 - 89.
Sherr CJ, Roberts JM. 1999 CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev13 12 1501 1512 - 90.
Lundberg AS, Weinberg RA. 1998 Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol18 2 753 761 - 91.
Blomberg I. Hoffmann I. 1999 Ectopic expression of Cdc25A accelerates the G(1)/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases. Mol Cell Biol19 9 6183 6194 - 92.
Sherr CJ, Roberts JM. 2004 Living with or without cyclins and cyclin-dependent kinases. Genes Dev18 22 2699 2711 - 93.
RN Booher Holman. P. S. Fattaey A. 1997 Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity. J Biol Chem272 35 22300 22306 - 94.
Sebastian B. Kakizuka A. Hunter T. 1993 Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15. Proc Natl Acad Sci U S A90 8 3521 3524 - 95.
Hoffmann I. Draetta G. Karsenti E. 1994 Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition. EMBO J13 18 4302 4310 - 96.
Gabrielli BG, Clark JM, McCormack AK, Ellem KA. 1997 Hyperphosphorylation of the N-terminal domain of Cdc25 regulates activity toward cyclin B1/Cdc2 but not cyclin A/Cdk2. J Biol Chem272 45 28607 28614 - 97.
Lammer C. Wagerer S. Saffrich R. Mertens D. Ansorge W. Hoffmann I. 1998 The cdc25B phosphatase is essential for the G2/M phase transition in human cells. J Cell Sci 111 ( Pt 16)(Pt 16):2445-2453. - 98.
Sexl V. Diehl J. A. Sherr C. J. Ashmun R. Beach D. Roussel M. F. 1999 A rate limiting function of cdc25A for S phase entry inversely correlates with tyrosine dephosphorylation of Cdk2. Oncogene18 3 573 582 - 99.
Ducruet AP, Lazo JS. 2003 Regulation of Cdc25A half-life in interphase by cyclin-dependent kinase 2 activity. J Biol Chem278 34 31838 31842 - 100.
Pagano M. Pepperkok R. Verde F. Ansorge W. Draetta G. 1992 Cyclin A is required at two points in the human cell cycle. EMBO J11 3 961 971 - 101.
Petersen B. O. Lukas J. Sorensen C. S. Bartek J. Helin K. 1999 Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization. EMBO J18 2 396 410 - 102.
Coverley D. Pelizon C. Trewick S. Laskey R. A. 2000 Chromatin-bound Cdc6 persists in S and G2 phases in human cells, while soluble Cdc6 is destroyed in a cyclin A-cdk2 dependent process. J Cell Sci 113 ( Pt 11)(Pt 11):1929-1938. - 103.
Alexandrow MG, Hamlin JL. 2005 Chromatin decondensation in S-phase involves recruitment of Cdk2 by Cdc45 and histone H1 phosphorylation. J Cell Biol168 6 875 886 - 104.
Garner-Hamrick P. A. Fisher C. 1998 Antisense phosphorothioate oligonucleotides specifically down-regulate cdc25B causing S-phase delay and persistent antiproliferative effects. Int J Cancer76 5 720 728 - 105.
Lindqvist A. Kallstrom H. Lundgren A. Barsoum E. Rosenthal C. K. 2005 Cdc25B cooperates with Cdc25A to induce mitosis but has a unique role in activating cyclin B1-Cdk1 at the centrosome. J Cell Biol171 1 35 45 - 106.
MS Chen Hurov. J. White L. S. Woodford-Thomas T. Piwnica-Worms H. 2001 Absence of apparent phenotype in mice lacking Cdc25C protein phosphatase. Mol Cell Biol21 12 3853 3861 - 107.
Lincoln A. J. Wickramasinghe D. Stein P. Schultz R. M. ME Palko De Miguel. M. P. et al. 2002 Cdc25b phosphatase is required for resumption of meiosis during oocyte maturation. Nat Genet30 4 446 449 - 108.
Ferguson A. M. White L. S. Donovan P. J. Piwnica-Worms H. 2005 Normal cell cycle and checkpoint responses in mice and cells lacking Cdc25B and Cdc25C protein phosphatases. Mol Cell Biol25 7 2853 2860 - 109.
Furuno N. den Elzen. N. Pines J. 1999 Human cyclin A is required for mitosis until mid prophase. J Cell Biol147 295 306 - 110.
Mitra J. Enders G. H. 2004 Cyclin A/Cdk2 complexes regulate activation of Cdk1 and Cdc25 phosphatases in human cells. Oncogene23 19 3361 3367 - 111.
Minshull J. Golsteyn R. Hill C. S. Hunt T. 1990 The A- and B-type cyclin associated cdc2 kinases in Xenopus turn on and off at different times in the cell cycle. EMBO J9 9 2865 2875 - 112.
Cans C. Ducommun B. Baldin V. 1999 Proteasome-dependent degradation of human CDC25B phosphatase. Mol Biol Rep 26(1-2):53-57. - 113.
Baldin V. Cans C. Knibiehler M. Ducommun B. 1997 Phosphorylation of human CDC25B phosphatase by CDK1-cyclin A triggers its proteasome-dependent degradation. J Biol Chem272 52 32731 32734 - 114.
Gabrielli B. G. MS Lee Walker. D. H. Piwnica-Worms H. Maller J. L. 1992 Cdc25 regulates the phosphorylation and activity of the Xenopus cdk2 protein kinase complex. J Biol Chem267 25 18040 18046 - 115.
Malumbres M. Barbacid M. 2005 Mammalian cyclin-dependent kinases. Trends Biochem Sci30 11 630 641 - 116.
De Boer L. Oakes V. Beamish H. Giles N. Stevens F. Somodevilla-Torres M. et al. 2008 Cyclin A/cdk2 coordinates centrosomal and nuclear mitotic events. Oncogene27 31 4261 4268 - 117.
Nishijima H. Nishitani H. Seki T. Nishimoto T. 1997 A dual-specificity phosphatase Cdc25B is an unstable protein and triggers34 cdc2)/cyclin B activation in hamster BHK21 cells arrested with hydroxyurea. J Cell Biol 138(5):1105-1116. - 118.
Timofeev O. Cizmecioglu O. Settele F. Kempf T. Hoffmann I. 2010 Cdc25 phosphatases are required for timely assembly of CDK1-cyclin B at the G2/M transition. J Biol Chem285 22 16978 16990 - 119.
Bailly E. Doree M. Nurse P. Bornens M. 1989 34cdc2 is located in both nucleus and cytoplasm; part is centrosomally associated at G2/M and enters vesicles at anaphase. EMBO J 8(13):3985-3995. - 120.
Gabrielli BG, De Souza CP, Tonks ID, Clark JM, Hayward NK, Ellem KA. 1996 Cytoplasmic accumulation of cdc25B phosphatase in mitosis triggers centrosomal microtubule nucleation in HeLa cells. J Cell Sci 109 ( Pt 5)(Pt 5):1081-1093. - 121.
Pines J. Hunter T. 1991 Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport. J Cell Biol115 1 1 17 - 122.
Hirota T. Kunitoku N. Sasayama T. Marumoto T. Zhang D. Nitta M. et al. 2003 Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells. Cell114 5 585 598 - 123.
Barr A. R. Gergely F. 2007 Aurora-A: the maker and breaker of spindle poles. J Cell Sci 120(Pt 17):2987-2996. - 124.
Dutertre S. Cazales M. Quaranta M. Froment C. Trabut V. Dozier C. et al. 2004 Phosphorylation of CDC25B by Aurora-A at the centrosome contributes to the G2 M transition. J Cell Sci 117(Pt 12):2523-2531. - 125.
Jackman M. Lindon C. Nigg E. A. Pines J. 2003 Active cyclin B1-Cdk1 first appears on centrosomes in prophase. Nat Cell Biol5 2 143 148 - 126.
Pines J. Hunter T. 1994 The differential localization of human cyclins A and B is due to a cytoplasmic retention signal in cyclin B. EMBO J13 16 3772 3781 - 127.
Hagting A. Karlsson C. Clute P. Jackman M. Pines J. 1998 MPF localization is controlled by nuclear export. EMBO J17 14 4127 4138 - 128.
Toyoshima F. Moriguchi T. Wada A. Fukuda M. Nishida E. 1998 Nuclear export of cyclin B1 and its possible role in the DNA damage-induced G2 checkpoint. EMBO J17 10 2728 2735 - 129.
Yang J. Bardes E. S. JD Moore Brennan. J. MA Powers Kornbluth. S. 1998 Control of cyclin B1 localization through regulated binding of the nuclear export factor CRM1. Genes Dev12 14 2131 2143 - 130.
Borgne A. Ostvold A. C. Flament S. Meijer L. 1999 Intra-M phase-promoting factor phosphorylation of cyclin B at the prophase/metaphase transition. J Biol Chem274 17 11977 11986 - 131.
Toyoshima-Morimoto F. Taniguchi E. Shinya N. Iwamatsu A. Nishida E. 2001 Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase. Nature410 6825 215 220 - 132.
Okano-Uchida T. Okumura E. Iwashita M. Yoshida H. Tachibana K. Kishimoto T. 2003 Distinct regulators for Plk1 activation in starfish meiotic and early embryonic cycles. EMBO J22 20 5633 5642 - 133.
Nakajima H. Toyoshima-Morimoto F. Taniguchi E. Nishida E. 2003 Identification of a consensus motif for Plk (Polo-like kinase) phosphorylation reveals Myt1 as a Plk1 substrate. J Biol Chem278 28 25277 25280 - 134.
Watanabe N. Arai H. Nishihara Y. Taniguchi M. Watanabe N. Hunter T. et al. 2004 M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCFbeta-TrCP. Proc Natl Acad Sci U S A101 13 4419 4424 - 135.
Baldin V. Pelpel K. Cazales M. Cans C. Ducommun B. 2002 Nuclear localization of CDC25B1 and serine 146 integrity are required for induction of mitosis. J Biol Chem277 38 35176 35182 - 136.
Lobjois V. Jullien D. Bouche J. P. Ducommun B. 2009 The polo-like kinase 1 regulates CDC25B-dependent mitosis entry. Biochim Biophys Acta1793 3 462 468 - 137.
Lobjois V. Froment C. Braud E. Grimal F. Burlet-Schiltz O. Ducommun B. et al. 2011 Study of the docking-dependent PLK1 phosphorylation of the CDC25B phosphatase. Biochem Biophys Res Commun410 1 87 90 - 138.
Qian Y. W. Erikson E. Taieb F. E. Maller J. L. 2001 The polo-like kinase Plx1 is required for activation of the phosphatase Cdc25C and cyclin B-Cdc2 in Xenopus oocytes. Mol Biol Cell12 6 1791 1799 - 139.
Roshak A. K. Capper E. A. Imburgia C. Fornwald J. Scott G. Marshall L. A. 2000 The human polo-like kinase, PLK, regulates cdc2/cyclin B through phosphorylation and activation of the cdc25C phosphatase. Cell Signal12 6 405 411 - 140.
Toyoshima-Morimoto F. Taniguchi E. Nishida E. 2002 Plk1 promotes nuclear translocation of human Cdc25C during prophase. EMBO Rep3 4 341 348 - 141.
Bahassi el M. Hennigan R. F. Myer D. L. Stambrook P. J. 2004 Cdc25C phosphorylation on serine 191 by Plk3 promotes its nuclear translocation. Oncogene23 15 2658 2663 - 142.
Bonni S. Ganuelas M. L. Petrinac S. Hudson J. W. 2008 Human Plk4 phosphorylates Cdc25C. Cell Cycle7 4 545 547 - 143.
Strausfeld U. Fernandez A. Capony J. P. Girard F. Lautredou N. Derancourt J. et al. 1994 Activation of34cdc2 protein kinase by microinjection of human cdc25C into mammalian cells. Requirement for prior phosphorylation of cdc25C by p34cdc2 on sites phosphorylated at mitosis. J Biol Chem 269(8):5989-6000. - 144.
Honda R. Ohba Y. Nagata A. Okayama H. Yasuda H. 1993 Dephosphorylation of human34cdc2 kinase on both Thr-14 and Tyr-15 by human cdc25B phosphatase. FEBS Lett 318(3):331-334. - 145.
Franckhauser C. Mamaeva D. Heron-Milhavet L. Fernandez A. Lamb N. J. 2010 Distinct pools of cdc25C are phosphorylated on specific TP sites and differentially localized in human mitotic cells. PLoS One 5(7):e11798. - 146.
Izumi T. Maller J. L. 1993 Elimination of cdc2 phosphorylation sites in the cdc25 phosphatase blocks initiation of M-phase. Mol Biol Cell4 12 1337 1350 - 147.
In: Marsh J, editor. Regulation of the Eukaryotic Cell New York: Wiley;Pines J. Hunter T. Cyclins A. in B. the Human. Cell Cycle. 1992 187 208 - 148.
Mailand N. Podtelejnikov A. V. Groth A. Mann M. Bartek J. Lukas J. 2002 Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability. EMBO J21 21 5911 5920 - 149.
Tumurbaatar I. Cizmecioglu O. Hoffmann I. Grummt I. Voit R. 2011 Human Cdc14B promotes progression through mitosis by dephosphorylating Cdc25 and regulating Cdk1/cyclin B activity. PLoS One 6(2):e14711. - 150.
Barford D. 2011 Structural insights into anaphase-promoting complex function and mechanism. Philos Trans R Soc Lond B Biol Sci366 1584 3605 3624 - 151.
Esteban V. MD Vazquez-Novelle Calvo. E. Bueno A. Sacristan M. P. 2006 Human Cdc14A reverses CDK1 phosphorylation of Cdc25A on serines 115 and 320. Cell Cycle5 24 2894 2898 - 152.
Donzelli M. Squatrito M. Ganoth D. Hershko A. Pagano M. Draetta G. F. 2002 Dual mode of degradation of Cdc25 A phosphatase. EMBO J21 18 4875 4884 - 153.
Kieffer I. Lorenzo C. Dozier C. Schmitt E. Ducommun B. 2007 Differential mitotic degradation of the CDC25B phosphatase variants. Oncogene26 57 7847 7858 - 154.
Rhind N. Furnari B. Russell P. 1997 Cdc2 tyrosine phosphorylation is required for the DNA damage checkpoint in fission yeast. Genes Dev11 4 504 511 - 155.
Boddy M. N. Furnari B. Mondesert O. Russell P. 1998 Replication checkpoint enforced by kinases Cds1 and Chk1. Science280 5365 909 912 - 156.
Zeng Y. Forbes K. C. Wu Z. Moreno S. Piwnica-Worms H. Enoch T. 1998 Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1. Nature395 6701 507 510 - 157.
Furnari B. Blasina A. Boddy M. N. Mc Gowan C. H. Russell P. 1999 Cdc25 inhibited in vivo and in vitro by checkpoint kinases Cds1 and Chk1. Mol Biol Cell10 4 833 845 - 158.
Branzei D. Foiani M. 2010 Maintaining genome stability at the replication fork. Nat Rev Mol Cell Biol11 3 208 219 - 159.
Melo J. Toczyski D. 2002 A unified view of the DNA-damage checkpoint. Curr Opin Cell Biol14 2 237 245 - 160.
Lopez-Girona A. Furnari B. Mondesert O. Russell P. 1999 Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein. Nature397 6715 172 175 - 161.
Ford J. C. al-Khodairy F. Fotou E. Sheldrick K. S. Griffiths D. J. Carr A. M. 1994 protein homologs required for the DNA damage checkpoint in fission yeast. Science265 5171 533 535 - 162.
Zeng Y. Piwnica-Worms H. 1999 DNA damage and replication checkpoints in fission yeast require nuclear exclusion of the Cdc25 phosphatase via 14-3-3 binding. Mol Cell Biol19 11 7410 7419 - 163.
Dai Y. Grant S. 2010 New insights into checkpoint kinase 1 in the DNA damage response signaling network. Clin Cancer Res16 2 376 383 - 164.
Niida H. Nakanishi M. 2006 DNA damage checkpoints in mammals. Mutagenesis21 1 3 9 - 165.
Minella A. C. Grim J. E. Welcker M. Clurman B. E. 2007 53 and SCFFbw7 cooperatively restrain cyclin E-associated genome instability. Oncogene 26(48):6948-6953. - 166.
Terada Y. Tatsuka M. Jinno S. Okayama H. 1995 Requirement for tyrosine phosphorylation of Cdk4 in G1 arrest induced by ultraviolet irradiation. Nature376 6538 358 362 - 167.
Mailand N. Falck J. Lukas C. Syljuasen R. G. Welcker M. Bartek J. et al. 2000 Rapid destruction of human Cdc25A in response to DNA damage. Science288 5470 1425 1429 - 168.
Goloudina A. Yamaguchi H. Chervyakova D. B. Appella E. Fornace A. J. Jr Bulavin D. V. 2003 Regulation of human Cdc25A stability by Serine 75 phosphorylation is not sufficient to activate a S phase checkpoint. Cell Cycle2 5 473 478 - 169.
Hassepass I. Voit R. Hoffmann I. 2003 Phosphorylation at serine 75 is required for UV-mediated degradation of human Cdc25A phosphatase at the S-phase checkpoint. J Biol Chem278 32 29824 29829 - 170.
MS Chen Ryan. CE Piwnica-Worms H. 2003 Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding. Mol Cell Biol23 21 7488 7497 - 171.
Jin J. Shirogane T. Xu L. Nalepa G. Qin J. Elledge S. J. et al. 2003 SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. Genes Dev17 24 3062 3074 - 172.
Zhao H. Watkins J. L. Piwnica-Worms H. 2002 Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints. Proc Natl Acad Sci U S A99 23 14795 14800 - 173.
Falck J. Mailand N. Syljuasen R. G. Bartek J. Lukas J. 2001 The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature410 6830 842 847 - 174.
Shreeram S. Hee W. K. Bulavin D. V. 2008 Cdc25A serine 123 phosphorylation couples centrosome duplication with DNA replication and regulates tumorigenesis. Mol Cell Biol28 24 7442 7450 - 175.
Madlener S. Rosner M. Krieger S. Giessrigl B. Gridling M. Vo T. P. et al. 2009 Short 42 degrees C heat shock induces phosphorylation and degradation of Cdc25A which depends on38MAPK Chk2 and 14.3.3. Hum Mol Genet 18(11):1990-2000. - 176.
Falck J. Petrini J. H. Williams B. R. Lukas J. Bartek J. 2002 The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nat Genet30 3 290 294 - 177.
Yaffe M. B. Rittinger K. Volinia S. Caron P. R. Aitken A. Leffers H. et al. 1997 The structural basis for 14-3-3:phosphopeptide binding specificity. Cell91 7 961 971 - 178.
Kasahara K. Goto H. Enomoto M. Tomono Y. Kiyono T. Inagaki M. 2010 gamma mediates Cdc25A proteolysis to block premature mitotic entry after DNA damage. EMBO J29 16 2802 2812 - 179.
Aitken A. 2002 Functional specificity in 14-3-3 isoform interactions through dimer formation and phosphorylation. Chromosome location of mammalian isoforms and variants. Plant Mol Biol50 6 993 1010 - 180.
Aitken A. Baxter H. Dubois T. Clokie S. Mackie S. Mitchell K. et al. 2002 Specificity of 14-3-3 isoform dimer interactions and phosphorylation. Biochem Soc Trans30 351 360 - 181.
Xiao Z. Chen Z. Gunasekera A. H. Sowin T. J. Rosenberg S. H. Fesik S. et al. 2003 Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents. J Biol Chem278 24 21767 21773 - 182.
Costanzo V. Robertson K. Ying C. Y. Kim E. Avvedimento E. Gottesman M. et al. 2000 Reconstitution of an ATM-dependent checkpoint that inhibits chromosomal DNA replication following DNA damage. Mol Cell6 3 649 659 - 183.
Molinari M. Mercurio C. Dominguez J. Goubin F. Draetta G. F. 2000 Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis. EMBO Rep1 1 71 79 - 184.
Busino L. Donzelli M. Chiesa M. Guardavaccaro D. Ganoth D. Dorrello N. V. et al. 2003 Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage. Nature426 6962 87 91 - 185.
Winston J. T. Strack P. Beer-Romero P. Chu C. Y. Elledge S. J. Harper J. W. 1999 The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev13 3 270 283 - 186.
Donzelli M. Busino L. Chiesa M. Ganoth D. Hershko A. Draetta G. F. 2004 Hierarchical order of phosphorylation events commits Cdc25A to betaTrCP-dependent degradation. Cell Cycle3 4 469 471 - 187.
Melixetian M. Klein D. K. Sorensen C. S. Helin K. 2009 NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint. Nat Cell Biol11 10 1247 1253 - 188.
Shieh S. Y. Ahn J. Tamai K. Taya Y. Prives C. 2000 The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate53 at multiple DNA damage-inducible sites. Genes Dev 14(3):289-300. - 189.
Khosravi R. Maya R. Gottlieb T. Oren M. Shiloh Y. Shkedy D. 1999 Rapid ATM-dependent phosphorylation of MDM2 precedes53 accumulation in response to DNA damage. Proc Natl Acad Sci U S A 96(26):14973-14977. - 190.
Maya R. Balass M. Kim S. T. Shkedy D. Leal J. F. Shifman O. et al. 2001 ATM-dependent phosphorylation of Mdm2 on serine 395: role in53 activation by DNA damage. Genes Dev 15(9):1067-1077. - 191.
Tritarelli A. Oricchio E. Ciciarello M. Mangiacasale R. Palena A. Lavia P. et al. 2004 53 localization at centrosomes during mitosis and postmitotic checkpoint are ATM-dependent and require serine 15 phosphorylation. Mol Biol Cell 15:3751. - 192.
el -Deiry W. S. Harper J. W. O’Connor P. M. Velculescu V. E. CE Canman Jackman. J. et al. 1994 WAF1/CIP1 is induced in53 G1 arrest and apoptosis. Cancer Res 54(5):1169-1174. - 193.
Watcharasit P. Bijur G. N. Zmijewski J. W. Song L. Zmijewska A. Chen X. et al. 2002 Direct, activating interaction between glycogen synthase kinase-3beta and53 after DNA damage. Proc Natl Acad Sci U S A 99(12):7951-7955. - 194.
Kang T. Wei Y. Honaker Y. Yamaguchi H. Appella E. Hung M. C. et al. 2008 GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers. Cancer Cell13 1 36 47 - 195.
Myer D. L. Robbins S. B. Yin M. Boivin G. P. Liu Y. Greis K. D. et al. 2011 Absence of polo-like kinase 3 in mice stabilizes Cdc25A after DNA damage but is not sufficient to produce tumors. Mutat Res 714(1-2):1-10. - 196.
Xie S. Wu H. Wang Q. Cogswell J. P. Husain I. Conn C. et al. 2001 Plk3 functionally links DNA damage to cell cycle arrest and apoptosis at least in part via the53 pathway. J Biol Chem 276(46):43305-43312. - 197.
Bahassi el M. Myer D. L. Mc Kenney R. J. Hennigan R. F. Stambrook P. J. 2006 Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage. Mutat Res 596(1-2):166-176. - 198.
Honaker Y. Piwnica-Worms H. 2010 Casein kinase 1 functions as both penultimate and ultimate kinase in regulating Cdc25A destruction. Oncogene29 23 3324 3334 - 199.
Piao S. Lee S. J. Xu Y. Gwak J. Oh S. Park B. J. et al. 2011 CK1epsilon targets Cdc25A for ubiquitin-mediated proteolysis under normal conditions and in response to checkpoint activation. Cell Cycle10 3 531 537 - 200.
Sorensen C. S. Syljuasen R. G. Falck J. Schroeder T. Ronnstrand L. Khanna K. K. et al. 2003 Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell3 3 247 258 - 201.
Shimuta K. Nakajo N. Uto K. Hayano Y. Okazaki K. Sagata N. 2002 Chk1 is activated transiently and targets Cdc25A for degradation at the Xenopus midblastula transition. EMBO J21 14 3694 3703 - 202.
Kanemori Y. Uto K. Sagata N. 2005 Beta-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases. Proc Natl Acad Sci U S A102 18 6279 6284 - 203.
Koledova Z. Kafkova L. R. Kramer A. Divoky V. 2010 DNA damage-induced degradation of Cdc25A does not lead to inhibition of Cdk2 activity in mouse embryonic stem cells. Stem Cells28 3 450 461 - 204.
Thomas Y. Coux O. Baldin V. 2010 betaTrCP-dependent degradation of CDC25B phosphatase at the metaphase-anaphase transition is a pre-requisite for correct mitotic exit. Cell Cycle9 21 4338 4350 - 205.
Bansal P. Lazo J. S. 2007 Induction of Cdc25B regulates cell cycle resumption after genotoxic stress. Cancer Res67 7 3356 3363 - 206.
Jin J. Ang X. L. Ye X. Livingstone M. Harper J. W. 2008 Differential roles for checkpoint kinases in DNA damage-dependent degradation of the Cdc25A protein phosphatase. J Biol Chem283 28 19322 19328 - 207.
Uto K. Inoue D. Shimuta K. Nakajo N. Sagata N. 2004 Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism. EMBO J23 16 3386 3396 - 208.
Bulavin D. V. Higashimoto Y. Popoff I. J. Gaarde W. A. Basrur V. Potapova O. et al. 2001 Initiation of a G2/M checkpoint after ultraviolet radiation requires38 kinase. Nature 411(6833):102-107. - 209.
Matsuoka S. Huang M. Elledge S. J. 1998 Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science282 5395 1893 1897 - 210.
Manke I. A. Nguyen A. Lim D. Stewart M. Q. Elia A. E. Yaffe M. B. 2005 MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Mol Cell17 1 37 48 - 211.
Uchida S. Yoshioka K. Kizu R. Nakagama H. Matsunaga T. Ishizaka Y. et al. 2009 Stress-activated mitogen-activated protein kinases c-Jun NH2-terminal kinase and38 target Cdc25B for degradation. Cancer Res 69(16):6438-6444. - 212.
Galaktionov K. Lee A. K. Eckstein J. Draetta G. Meckler J. Loda M. et al. 1995 CDC25 phosphatases as potential human oncogenes. Science269 5230 1575 1577 - 213.
Gabrielli BG, Clark JM, McCormack AK, Ellem KA. 1997 Ultraviolet light-induced G2 phase cell cycle checkpoint blocks cdc25-dependent progression into mitosis. Oncogene15 7 749 758 - 214.
Lemaire M. Ducommun B. Nebreda A. R. 2010 UV-induced downregulation of the CDC25B protein in human cells. FEBS Lett584 6 1199 1204 - 215.
Deng J. Harding H. P. Raught B. Gingras A. C. Berlanga J. J. Scheuner D. et al. 2002 Activation of GCN2 in UV-irradiated cells inhibits translation. Curr Biol12 15 1279 1286 - 216.
Uchida S. Kuma A. Ohtsubo M. Shimura M. Hirata M. Nakagama H. et al. 2004 Binding of 14-3-3beta but not 14-3-3sigma controls the cytoplasmic localization of CDC25B: binding site preferences of 14-3-3 subtypes and the subcellular localization of CDC25B. J Cell Sci 117(Pt 14):3011-3020. - 217.
Dalal S. N. Schweitzer C. M. Gan J. De Caprio J. A. 1999 Cytoplasmic localization of human cdc25C during interphase requires an intact 14-3-3 binding site. Mol Cell Biol19 6 4465 4479 - 218.
Barth H. Hoffmann I. Kinzel V. 1996 Radiation with 1 Gy prevents the activation of the mitotic inducers mitosis-promoting factor (MPF) and cdc25-C in HeLa cells. Cancer Res56 10 2268 2272 - 219.
Peng C. Y. Graves P. R. Thoma R. S. Wu Z. AS Shaw-Worms Piwnica. H. 1997 Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science277 5331 1501 1505 - 220.
Sanchez Y. Wong C. Thoma R. S. Richman R. Wu Z. Piwnica-Worms H. et al. 1997 Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science277 5331 1497 1501 - 221.
Ogg S. Gabrielli B. Piwnica-Worms H. 1994 Purification of a serine kinase that associates with and phosphorylates human Cdc25C on serine 216. J Biol Chem269 48 30461 30469 - 222.
Brown A. L. Lee C. H. Schwarz J. K. Mitiku N. Piwnica-Worms H. Chung J. H. 1999 A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage. Proc Natl Acad Sci U S A96 7 3745 3750 - 223.
Morris M. C. Heitz A. Mery J. Heitz F. Divita G. 2000 An essential phosphorylation-site domain of human cdc25C interacts with both 14-3-3 and cyclins. J Biol Chem275 37 28849 28857 - 224.
Graves P. R. Lovly C. M. Uy G. L. Piwnica-Worms H. 2001 Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding. Oncogene20 15 1839 1851 - 225.
Chan P. M. Ng Y. W. Manser E. 2011 A robust protocol to map binding sites of the 14-3-3 interactome: Cdc25C requires phosphorylation of both S216 and S263 to bind 14-3-3. Mol Cell Proteomics 10(3):M110.005157. - 226.
Esmenjaud-Mailhat C. Lobjois V. Froment C. Golsteyn R. M. Monsarrat B. Ducommun B. 2007 Phosphorylation of CDC25C at S263 controls its intracellular localisation. FEBS Lett581 21 3979 3985 - 227.
O’Neill T. Giarratani L. Chen P. Iyer L. Lee C. H. Bobiak M. et al. 2002 Determination of substrate motifs for human Chk1 and hCds1/Chk2 by the oriented peptide library approach. J Biol Chem277 18 16102 16115 - 228.
Kumagai A. Dunphy W. G. 1999 Binding of 14-3-3 proteins and nuclear export control the intracellular localization of the mitotic inducer Cdc25. Genes Dev13 9 1067 1072 - 229.
Kumagai A. Yakowec P. S. Dunphy W. G. 1998 proteins act as negative regulators of the mitotic inducer Cdc25 in Xenopus egg extracts. Mol Biol Cell9 2 345 354 - 230.
Kumagai A. Guo Z. Emami K. H. Wang S. X. Dunphy W. G. 1998 The Xenopus Chk1 protein kinase mediates a caffeine-sensitive pathway of checkpoint control in cell-free extracts. J Cell Biol142 6 1559 1569 - 231.
Hutchins J. R. Dikovskaya D. Clarke P. R. 2002 Dephosphorylation of the inhibitory phosphorylation site S287 in Xenopus Cdc25C by protein phosphatase-2A is inhibited by 14-3-3 binding. FEBS Lett 528(1-3):267-271. - 232.
Sorensen C. S. Syljuasen R. G. Lukas J. Bartek J. 2004 ATR, Claspin and the Rad9-Rad1-Hus1 complex regulate Chk1 and Cdc25A in the absence of DNA damage. Cell Cycle3 7 941 945 - 233.
Kreutzer J. Guerra B. 2007 The regulatory beta-subunit of protein kinase CK2 accelerates the degradation of CDC25A phosphatase through the checkpoint kinase Chk1. Int J Oncol31 5 1251 1259 - 234.
Schwindling S. L. Noll A. Montenarh M. Gotz C. 2004 Mutation of a CK2 phosphorylation site in cdc25C impairs importin alpha/beta binding and results in cytoplasmic retention. Oncogene23 23 4155 4165 - 235.
Theis-Febvre N. Filhol O. Froment C. Cazales M. Cochet C. Monsarrat B. et al. 2003 Protein kinase CK2 regulates CDC25B phosphatase activity. Oncogene22 2 220 232 - 236.
Schmitt E. Boutros R. Froment C. Monsarrat B. Ducommun B. Dozier C. 2006 CHK1 phosphorylates CDC25B during the cell cycle in the absence of DNA damage. J Cell Sci 119(Pt 20):4269-4275. - 237.
Kramer A. Mailand N. Lukas C. Syljuasen R. G. Wilkinson C. J. Nigg E. A. et al. 2004 Centrosome-associated Chk1 prevents premature activation of cyclin-B-Cdk1 kinase. Nat Cell Biol6 9 884 891 - 238.
Forrest A. Gabrielli B. 2001 Cdc25B activity is regulated by 14-3-3. Oncogene20 32 4393 4401 - 239.
Giles N. Forrest A. Gabrielli B. 2003 acts as an intramolecular bridge to regulate cdc25B localization and activity. J Biol Chem278 31 28580 28587 - 240.
Davezac N. Baldin V. Gabrielli B. Forrest A. Theis-Febvre N. Yashida M. et al. 2000 Regulation of CDC25B phosphatases subcellular localization. Oncogene19 18 2179 2185 - 241.
Stanford JS, Ruderman JV. 2005 Changes in regulatory phosphorylation of Cdc25C Ser287 and Wee1 Ser549 during normal cell cycle progression and checkpoint arrests. Mol Biol Cell16 12 5749 5760 - 242.
Brown E. J. Baltimore D. 2003 Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance. Genes Dev17 5 615 628 - 243.
Liu Q. Guntuku S. Cui X. S. Matsuoka S. Cortez D. Tamai K. et al. 2000 Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev14 12 1448 1459 - 244.
Yang J. Winkler K. Yoshida M. Kornbluth S. 1999 Maintenance of G2 arrest in the Xenopus oocyte: a role for 14-3-3-mediated inhibition of Cdc25 nuclear import. EMBO J18 8 2174 2183 - 245.
Brondello J. M. Boddy M. N. Furnari B. Russell P. 1999 Basis for the checkpoint signal specificity that regulates Chk1 and Cds1 protein kinases. Mol Cell Biol19 6 4262 4269 - 246.
Bulavin D. V. Higashimoto Y. Demidenko Z. N. Meek S. Graves P. Phillips C. et al. 2003 Dual phosphorylation controls Cdc25 phosphatases and mitotic entry. Nat Cell Biol5 6 545 551 - 247.
Bulavin D. V. Demidenko Z. N. Phillips C. Moody S. A. Fornace A. J. Jr 2003 Phosphorylation of Xenopus Cdc25C at Ser285 interferes with ability to activate a DNA damage replication checkpoint in pre-midblastula embryos. Cell Cycle2 3 263 266 - 248.
Margolis S. S. Perry J. A. Forester C. M. Nutt L. K. Guo Y. MJ Jardim et. al 2006 Role for the2A B56delta phosphatase in regulating 14-3-3 release from Cdc25 to control mitosis. Cell 127(4):759-773. - 249.
Margolis S. S. Perry J. A. Weitzel D. H. Freel C. D. Yoshida M. Haystead T. A. et al. 2006 A role for1 in the Cdc2/Cyclin B-mediated positive feedback activation of Cdc25. Mol Biol Cell 17(4):1779-1789. - 250.
Cunat S. Anahory T. Berthenet C. Hedon B. Franckhauser C. Fernandez A. et al. 2008 The cell cycle control protein cdc25C is present, and phosphorylated on serine 214 in the transition from germinal vesicle to metaphase II in human oocyte meiosis. Mol Reprod Dev75 7 1176 1184 - 251.
Margolis S. S. Walsh S. Weiser D. C. Yoshida M. Shenolikar S. Kornbluth S. 2003 1 control of M phase entry exerted through 14-3-3-regulated Cdc25 dephosphorylation. EMBO J 22(21):5734-5745. - 252.
Ku N. O. Michie S. Resurreccion E. Z. Broome R. L. Omary M. B. 2002 Keratin binding to 14-3-3 proteins modulates keratin filaments and hepatocyte mitotic progression. Proc Natl Acad Sci U S A99 7 4373 4378 - 253.
Clarke P. R. Hoffmann I. Draetta G. Karsenti E. 1993 Dephosphorylation of cdc25-C by a type-2A protein phosphatase: specific regulation during the cell cycle in Xenopus egg extracts. Mol Biol Cell4 4 397 411 - 254.
Crenshaw D. G. Yang J. Means A. R. Kornbluth S. 1998 The mitotic peptidyl-prolyl isomerase, Pin1, interacts with Cdc25 and Plx1. EMBO J17 5 1315 1327 - 255.
Zhou X. Z. Kops O. Werner A. Lu P. J. Shen M. Stoller G. et al. 2000 Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol Cell6 4 873 883 - 256.
Stukenberg PT, Kirschner MW. 2001 Pin1 acts catalytically to promote a conformational change in Cdc25. Mol Cell7 5 1071 1083 - 257.
Winkler K. E. Swenson K. I. Kornbluth S. Means A. R. 2000 Requirement of the prolyl isomerase Pin1 for the replication checkpoint. Science287 5458 1644 1647 - 258.
Forester C. M. Maddox J. Louis J. V. Goris J. Virshup D. M. 2007 Control of mitotic exit by2A regulation of Cdc25C and Cdk1. Proc Natl Acad Sci U S A 104(50):19867-19872. - 259.
Astuti P. Boutros R. Ducommun B. Gabrielli B. 2010 Mitotic phosphorylation of Cdc25B Ser321 disrupts 14-3-3 binding to the high affinity Ser323 site. J Biol Chem285 45 34364 34370 - 260.
Hermeking H. Lengauer C. Polyak K. He T. C. Zhang L. Thiagalingam S. et al. 1997 sigma is a53 inhibitor of G2/M progression. Mol Cell 1(1):3-11. - 261.
Wilson-Grady J. T. Villén J. Gygi S. P. 2008 Phosphoproteome analysis of fission yeast. Journal of Proteome Research7 3 1088 1097 - 262.
Kinoshita N. Ohkura H. Yanagida M. 1990 Distinct, essential roles of type 1 and 2A protein phosphatases in the control of the fission yeast cell division cycle. Cell63 2 405 415 - 263.
Kinoshita N. Yamano H. Niwa H. Yoshida T. Yanagida M. 1993 Negative regulation of mitosis by the fission yeast protein phosphatase ppa2. Genes Dev7 6 1059 1071 - 264.
Ohkura H. Adachi Y. Kinoshita N. Niwa O. Toda T. Yanagida M. 1988 Cold-sensitive and caffeine-supersensitive mutants of the Schizosaccharomyces pombe dis genes implicated in sister chromatid separation during mitosis. EMBO J7 5 1465 1473 - 265.
Cargnello M. Roux P. P. 2011 Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev75 1 50 83 - 266.
Shaul Y. D. Seger R. 2007 The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim Biophys Acta1773 8 1213 1226 - 267.
Liu J. Grimison B. Maller J. L. 2007 New insight into metaphase arrest by cytostatic factor: from establishment to release. Oncogene26 9 1286 1289 - 268.
Rauh N. R. Schmidt A. Bormann J. Nigg E. A. Mayer T. U. 2005 Calcium triggers exit from meiosis II by targeting the APC/C inhibitor XErp1 for degradation. Nature437 7061 1048 1052 - 269.
Chun J. AS Chau Maingat. F. G. Edmonds S. D. Ostergaard H. L. Shibuya E. K. 2005 Phosphorylation of Cdc25C by90Rsk contributes to a G2 cell cycle arrest in Xenopus cycling egg extracts. Cell Cycle 4(1):148-154. - 270.
Hutchins J. R. Dikovskaya D. Clarke P. R. 2003 Regulation of Cdc2/cyclin B activation in Xenopus egg extracts via inhibitory phosphorylation of Cdc25C phosphatase by Ca(2+)/calmodulin-dependent protein [corrected]. kinase II. Mol Biol Cell14 10 4003 4014 - 271.
Wang R. Jung S. Y. Wu C. F. Qin J. Kobayashi R. Gallick G. E. et al. 2010 Direct roles of the signaling kinase RSK2 in Cdc25C activation during Xenopus oocyte maturation. Proc Natl Acad Sci U S A107 46 19885 19890 - 272.
Wang R. He G. Nelman-Gonzalez M. Ashorn C. L. Gallick G. E. Stukenberg P. T. et al. 2007 Regulation of Cdc25C by ERK-MAP kinases during the G2/M transition. Cell128 6 1119 1132 - 273.
Astuti P. Pike T. Widberg C. Payne E. Harding A. Hancock J. et al. 2009 MAPK pathway activation delays G2/M progression by destabilizing Cdc25B. J Biol Chem284 49 33781 33788 - 274.
Patel R. Holt M. Philipova R. Moss S. Schulman H. Hidaka H. et al. 1999 Calcium/calmodulin-dependent phosphorylation and activation of human Cdc25-C at the G2/M phase transition in HeLa cells. J Biol Chem274 12 7958 7968 - 275.
Planas-Silva MD, Means AR. 1992 Expression of a constitutive form of calcium/calmodulin dependent protein kinase II leads to arrest of the cell cycle in G2. EMBO J11 2 507 517 - 276.
Peng C. Y. Graves P. R. Ogg S. Thoma R. S. Byrnes M. J,3rd Wu. Z. et al. 1998 C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding. Cell Growth Differ9 3 197 208 - 277.
Izumi T. Maller J. L. 1995 Phosphorylation and activation of the Xenopus Cdc25 phosphatase in the absence of Cdc2 and Cdk2 kinase activity. Mol Biol Cell6 2 215 226 - 278.
Eymin B. Claverie P. Salon C. Brambilla C. Brambilla E. Gazzeri S. 2006 14ARF triggers G2 arrest through ERK-mediated Cdc25C phosphorylation, ubiquitination and proteasomal degradation. Cell Cycle 5(7):759-765. - 279.
Kotlyarov A. Yannoni Y. Fritz S. Laass K. Telliez J. B. Pitman D. et al. 2002 Distinct cellular functions of MK2. Mol Cell Biol22 13 4827 4835 - 280.
Uchida S. Watanabe N. Kudo Y. Yoshioka K. Matsunaga T. Ishizaka Y. et al. 2011 SCFbeta(TrCP) mediates stress-activated MAPK-induced Cdc25B degradation. J Cell Sci 124(Pt 16):2816-2825. - 281.
Gutierrez G. J. Tsuji T. Cross J. V. Davis R. J. Templeton D. J. Jiang W. et al. 2010 JNK-mediated phosphorylation of Cdc25C regulates cell cycle entry and G(2)/M DNA damage checkpoint. J Biol Chem285 19 14217 14228 - 282.
Goss V. L. Cross J. V. Ma Qian K. Mola Y. Templeton P. W. D. J. 2003 SAPK/JNK regulates cdc2/cyclin B kinase through phosphorylation and inhibition of cdc25c. Cell Signal15 7 709 718 - 283.
Lopez-Aviles S. Grande M. Gonzalez M. Helgesen A. L. Alemany V. Sanchez-Piris M. et al. 2005 Inactivation of the Cdc25 phosphatase by the stress-activated Srk1 kinase in fission yeast. Mol Cell17 1 49 59 - 284.
Smith D. A. BA Morgan Quinn. J. 2010 Stress signalling to fungal stress-activated protein kinase pathways. FEMS Microbiol Lett306 1 1 8 - 285.
Stanford JS, Lieberman SL, Wong VL, Ruderman JV. 2003 Regulation of the G2/M transition in oocytes of xenopus tropicalis. Dev Biol260 2 438 448 - 286.
Duckworth BC, Weaver JS, Ruderman JV. 2002 G2 arrest in Xenopus oocytes depends on phosphorylation of cdc25 by protein kinase A. Proc Natl Acad Sci U S A99 26 16794 16799 - 287.
Pirino G. Wescott M. P. Donovan P. J. 2009 Protein kinase A regulates resumption of meiosis by phosphorylation of Cdc25B in mammalian oocytes. Cell Cycle8 4 665 670 - 288.
Bachmann M. Moroy T. 2005 The serine/threonine kinase Pim-1. Int J Biochem Cell Biol37 4 726 730 - 289.
Mochizuki T. Kitanaka C. Noguchi K. Muramatsu T. Asai A. Kuchino Y. 1999 Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase. Implications for the Pim-1-mediated activation of the c-Myc signaling pathway. J Biol Chem274 26 18659 18666 - 290.
Wang Z. Bhattacharya N. Mixter P. F. Wei W. Sedivy J. Magnuson N. S. 2002 Phosphorylation of the cell cycle inhibitor21Cip1 WAF1 by Pim-1 kinase. Biochim Biophys Acta 1593(1):45-55. - 291.
Bachmann M. Hennemann H. Xing P. X. Hoffmann I. Moroy T. 2004 The oncogenic serine/threonine kinase Pim-1 phosphorylates and inhibits the activity of Cdc25C-associated kinase 1 (C-TAK1): a novel role for Pim-1 at the G2/M cell cycle checkpoint. J Biol Chem279 46 48319 48328 - 292.
Davezac N. Baldin V. Blot J. Ducommun B. Tassan J. P. 2002 Human pEg3 kinase associates with and phosphorylates CDC25B phosphatase: a potential role for pEg3 in cell cycle regulation. Oncogene21 50 7630 7641 - 293.
Mirey G. Chartrain I. Froment C. Quaranta M. Bouche J. P. Monsarrat B. et al. 2005 CDC25B phosphorylated by pEg3 localizes to the centrosome and the spindle poles at mitosis. Cell Cycle4 6 806 811 - 294.
Nance J. 2005 PAR proteins and the establishment of cell polarity during C. elegans development.Bioessays27 126 135 - 295.
Rivers D. M. Moreno S. Abraham M. Ahringer J. 2008 PAR proteins direct asymmetry of the cell cycle regulators Polo-like kinase and Cdc25. J Cell Biol180 5 877 885 - 296.
Kristjansdottir K. Rudolph J. 2004 Cdc25 phosphatases and cancer. Chem Biol11 8 1043 1051 - 297.
Loffler H. Syljuasen R. G. Bartkova J. Worm J. Lukas J. Bartek J. 2003 Distinct modes of deregulation of the proto-oncogenic Cdc25A phosphatase in human breast cancer cell lines. Oncogene22 50 8063 8071 - 298.
Galaktionov K. Chen X. Beach D. 1996 Cdc25 cell-cycle phosphatase as a target of c-myc. Nature382 6591 511 517 - 299.
Dong J. Zeng B. H. Xu L. H. Wang J. Y. Li M. Z. MS Zeng et. al 2010 Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma. J Transl Med 8:81. - 300.
Bugler B. Schmitt E. Aressy B. Ducommun B. 2010 Unscheduled expression of CDC25B in S-phase leads to replicative stress and DNA damage. Mol Cancer 9:29. - 301.
Planelles V. Benichou S. 2009 Vpr and its interactions with cellular proteins. Curr Top Microbiol Immunol339 177 200 - 302.
Huard S. Elder R. T. Liang D. Li G. Zhao R. Y. 2008 Human immunodeficiency virus type 1 Vpr induces cell cycle G2 arrest through Srk1/MK2-mediated phosphorylation of Cdc25. J Virol82 6 2904 2917 - 303.
Matsuda N. Tanaka H. Yamazaki S. Suzuki J. Tanaka K. Yamada T. et al. 2006 HIV-1 Vpr induces G2 cell cycle arrest in fission yeast associated with Rad24/14-3-3-dependent, Chk1/Cds1 independent Wee1 upregulation. Microbes Infect 8(12-13):2736-2744. - 304.
Elder R. T. Yu M. Chen M. Zhu X. Yanagida M. Zhao Y. 2001 HIV-1 Vpr induces cell cycle G2 arrest in fission yeast (Schizosaccharomyces pombe) through a pathway involving regulatory and catalytic subunits of2A and acting on both Wee1 and Cdc25. Virology 287(2):359-370. - 305.
Frazer C. Young P. G. 2012 Carboxy-terminal phosphorylation sites in Cdc25 contribute to enforcement of the DNA damage and replication checkpoints in fission yeast. Curr Genetics,DOI s00294-012-0379-1